LPancreas logo

Unlocking the Power of Biomarker Discovery and Machine Learning for Diabetes Management

Estimate Pancreatic Decline

Estimate Pancreatic Decline

An Innovative Approach to Combating Diabetes

PREDIABETES

10% of Global Population has Prediabetes
Non-invasive Diagnostics

Screening and Prevention

Informed timely interventions

DIABETES TYPE II

>1/2 Billion w/ Diabetes 2 (2M New Cases/Year)

DIABETES TYPE II
Precision Treatment
Informed treatment choice

LADA

One out of Ten Diabetes Cases
LADA
Accurate LADA diagnosis
(Latent Autoimmune Diabetes in Adults)

DIABETES TYPE I

8.4 Million Individuals Suffer from Diabetes type 1
DIABETES TYPE I

Immunotherapy companion diagnostics

GESTATIONAL DIABETES

10% of pregnacies

Gestational Diabetes

Screening for after-birth effects of gestational diabetes

LPancreas Diagnostic Kit for the onset of diabetes

How it works: a unique innovation in diabetes

1

Liquid Biopsy

Liquid Biopsy

Minimally-invasive dynamic mirror of
the pancreas

2

Epigenetic Biomarker Panel

Epigenetic Biomarker Panel

Combination of tissue specific biomarkers (not a single one) providing a stronger predictive
value

3

Automated Machine Learning

AutoML

Use our LPancreas dashboard and our advanced AI modeling

FAQ

LPancreas is a product of ABCureD PC.

The test is implemented in a standard biopathology lab.
LPancreas is a minimally-invasive test. It requires a standard blood-sampling by a health professional in the lab.
The result can typically be delivered after one working day.
The test is based on standard PCR methodology. The PCR result is fed into a smart app to produce a score indicative of pancreatic decline.

The test demonstrates the highest ever reported performance for a model in detecting diabetes. See Karaglani et al., JCM 2022.

There is no medical alternative for detecting pancreatic cell-loss.
LPancreas complements current medical practice into diabetes diagnosis and monitoring.

The practitioner has an insight about the progress of patient’s pancreatic decline, indicative of the progress of the pathology.

LPancreas is designed to transform lives and revolutionize healthcare management. With our cutting-edge technology, users can experience an enhanced quality of life, ensuring a healthier and more fulfilling life. By predicting their future, patients can significantly reduce healthcare costs, alleviating financial burdens while accessing comprehensive health solutions. Empowering users with valuable insights, our platform facilitates informed decisions by their doctors, leading to timely and correct interventions. Moreover, our advanced system promotes improved treatment responses, fostering overall health and well-being. Emphasizing personalized care, our product enables tailored management through lifestyle modifications, effectively preventing the onset of diabetes.

Implemented with the support of 

REQUEST A MEETING

Fill out the form below, and we will be in touch shortly.
Contact Information
Company Information
Preferred Date and Time Selection